M003

R-(−)-Deprenyl -hydrochlorid

≥98% (HPLC), MAO-B inhibitor, powder

• Synonym(e): (R)-(−)-N,α-Dimethyl-N-(2-propinyl)-phenethylamin -hydrochlorid, (R)-(−)-N-α-Dimethyl-N-2-propinyl-benzolethanamin -hydrochlorid, Selegilin -hydrochlorid
• Empirische Formel (Hill-System): C₁₃H₁₇N · HCl
• CAS-Nummer: 14611-52-0
• Molekulargewicht: 223.74
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278577
• NACRES: NA.77
• MDL number: MFCD00069299
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Produktname: R-(−)-Deprenyl -hydrochlorid, powder, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]25/D −10.8°, c = 6.48 in H₂O(lit.)
• color: white
• mp: 141-142 °C
• solubility: H₂O: >10 mg/mL
• originator: Sanofi Aventis
• SMILES string: Cl[H].C[C@H](Cc1ccccc1)N(C)CC#C
• InChI: 1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
• InChI key: IYETZZCWLLUHIJ-UTONKHPSSA-N
• Gene Information: human ... MAOB(4129)

Beschreibung

Biochem/physiol Actions

Selektiver MAO-B Hemmer; Antiparkinsonmittel.

Features and Benefits

This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• pictograms: GHS07
• signalword: Warning
• hcodes: H302,H336
• pcodes: P301 + P312 + P330
• Hazard Classifications: Acute Tox. 4 Oral - STOT SE 3
• target_organs: Central nervous system
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 1
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)